{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T20:16:02Z","timestamp":1790972162052,"version":"4.1.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"DOI":"10.1186\/s13098-025-01720-w","type":"journal-article","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T08:56:51Z","timestamp":1747385811000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Prevalence of metabolic syndrome in ankylosing spondylitis: a multi national meta-analysis study"],"prefix":"10.1186","volume":"17","author":[{"given":"Sandeep Samethadka","family":"Nayak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwame Boateng","family":"Agyeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khushbu Viresh","family":"Janani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Jafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Amouzadeh","family":"Lichahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pubali","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Hashemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nimra","family":"Shafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin","family":"Sahli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehsan","family":"Amini-Salehi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narsimha Rao","family":"Keetha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,16]]},"reference":[{"key":"1720_CR1","unstructured":"Wenker KJ, Quint JM. Ankylosing spondylitis, StatPearls, StatPearls publishing copyright \u00a9 2025. StatPearls Publishing LLC., Treasure Island (FL); 2025."},{"key":"1720_CR2","unstructured":"Agrawal P, Tote S, Sapkale B. Diagnosis Treat Ankyl Spondylitis Cureus. 2024;16(1):e52559."},{"key":"1720_CR3","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2147\/OARRR.S212456","volume":"11","author":"MR Shim","year":"2019","unstructured":"Shim MR. Efficacy of TNF inhibitors in advanced ankylosing spondylitis with total spinal fusion: case report and review of literature. Open Access Rheumatol. 2019;11:173\u20137.","journal-title":"Open Access Rheumatol"},{"issue":"18","key":"1720_CR4","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.3748\/wjg.v25.i18.2162","volume":"25","author":"GE Fragoulis","year":"2019","unstructured":"Fragoulis GE, Liava C, Daoussis D, Akriviadis E, Garyfallos A, Dimitroulas T. Inflammatory bowel diseases and spondyloarthropathies: from pathogenesis to treatment. World J Gastroenterol. 2019;25(18):2162\u201376.","journal-title":"World J Gastroenterol"},{"key":"1720_CR5","unstructured":"Sen R, Goyal A, Hurley JA. Seronegative spondyloarthropathy, StatPearls, StatPearls publishing copyright \u00a9 2025. StatPearls Publishing LLC., Treasure Island (FL); 2025."},{"issue":"12","key":"1720_CR6","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.3899\/jrheum.2024-0939","volume":"51","author":"LC Coates","year":"2024","unstructured":"Coates LC, Schett G, Wang C, Weiss PF. Unmet needs in spondyloarthritis: pathogenesis, clinical trial design, and nonpharmacologic therapy. J Rheumatol. 2024;51(12):1254\u20138.","journal-title":"J Rheumatol"},{"issue":"10","key":"1720_CR7","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1007\/s10067-017-3623-8","volume":"36","author":"DG Maia","year":"2017","unstructured":"Maia DG, Augusto KL, Bezerra MC, Rodrigues CEM. Metabolic syndrome in patients with ankylosing spondylitis receiving anti-TNF\u03b1 therapy: association with predictors of cardiovascular risk. Clin Rheumatol. 2017;36(10):2371\u20136.","journal-title":"Clin Rheumatol"},{"key":"1720_CR8","doi-asserted-by":"publisher","first-page":"477","DOI":"10.2147\/DMSO.S197745","volume":"12","author":"M Liu","year":"2019","unstructured":"Liu M, Huang Y, Huang Z, Huang Q, Guo X, Wang Y, Deng W, Huang Z, Li T. Prevalence of metabolic syndrome and its associated factors in Chinese patients with ankylosing spondylitis. Diabetes Metab Syndr Obes. 2019;12:477\u201384.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"1720_CR9","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41413-019-0057-8","volume":"7","author":"W Zhu","year":"2019","unstructured":"Zhu W, He X, Cheng K, Zhang L, Chen D, Wang X, Qiu G, Cao X, Weng X. Ankylosing spondylitis: etiology, pathogenesis, and treatments. Bone Res. 2019;7:22.","journal-title":"Bone Res"},{"key":"1720_CR10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.clnesp.2024.11.011","volume":"65","author":"A Habibi","year":"2025","unstructured":"Habibi A, Letafatkar N, Sattari N, Nobakht S, Rafat Z, Soltani Moghadam S, Mirdamadi A, Javid M, Jamilian P, Hassanipour S, Keivanlou M-H, Amini-Salehi E. Modulation of inflammatory markers in type 2 diabetes mellitus through gut microbiome-targeted interventions: an umbrella review on meta-analyses. Clin Nutr ESPEN. 2025;65:93\u2013104.","journal-title":"Clin Nutr ESPEN"},{"issue":"8","key":"1720_CR11","first-page":"e67428","volume":"16","author":"RH Dhondge","year":"2024","unstructured":"Dhondge RH, Agrawal S, Patil R, Kadu A, Kothari M. A comprehensive review of metabolic syndrome and its role in cardiovascular disease and type 2 diabetes mellitus: mechanisms, risk factors, and management. Cureus. 2024;16(8):e67428.","journal-title":"Cureus"},{"key":"1720_CR12","doi-asserted-by":"crossref","unstructured":"Rus M, Crisan S, Andronie-Cioara FL, Indries M, Marian P, Pobirci OL. A.I. Ardelean, prevalence and risk factors of metabolic syndrome: A prospective study on cardiovascular health. Med (Kaunas) 59(10) (2023).","DOI":"10.3390\/medicina59101711"},{"key":"1720_CR13","doi-asserted-by":"publisher","first-page":"111679","DOI":"10.1016\/j.diabres.2024.111679","volume":"211","author":"Z Wu","year":"2024","unstructured":"Wu Z, Luo S, Cai D, Lin W, Hu X, Zhou T, Zhang X, Feng Y, Luo J. The causal relationship between metabolic syndrome and its components and cardiovascular disease: A Mendelian randomization study. Diabetes Res Clin Pract. 2024;211:111679.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"1720_CR14","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1186\/s12891-021-04222-8","volume":"22","author":"C Petcharat","year":"2021","unstructured":"Petcharat C, Srinonprasert V, Chiowchanwisawakit P. Association between syndesmophyte and metabolic syndrome in patients with psoriatic arthritis or ankylosing spondylitis: a cross-sectional study. BMC Musculoskelet Disord. 2021;22(1):367.","journal-title":"BMC Musculoskelet Disord"},{"issue":"1","key":"1720_CR15","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1186\/s12944-024-02378-5","volume":"23","author":"SM Hashemi","year":"2024","unstructured":"Hashemi SM, Kheirandish M, Rafati S, Ghazalgoo A, Amini-Salehi E, Keivanlou M-H, Abbaszadeh S, Saberian P, Rahimi A. The association between neutrophil and lymphocyte to high-density lipoprotein cholesterol ratio and metabolic syndrome among Iranian population, finding from Bandare Kong cohort study. Lipids Health Dis. 2024;23(1):393.","journal-title":"Lipids Health Dis"},{"key":"1720_CR16","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.clnesp.2023.07.087","volume":"57","author":"A Mahapatro","year":"2023","unstructured":"Mahapatro A, Bawna F, Kumar V, Daryagasht AA, Gupta S, Raghuma N, Moghdam SS, Kolla A, Mahapatra SS, Sattari N, Amini-Salehi E, Nayak SS. Anti-inflammatory effects of probiotics and synbiotics on patients with non-alcoholic fatty liver disease: an umbrella study on meta-analyses. Clin Nutr ESPEN. 2023;57:475\u201386.","journal-title":"Clin Nutr ESPEN"},{"key":"1720_CR17","doi-asserted-by":"publisher","first-page":"155002","DOI":"10.1016\/j.cyto.2020.155002","volume":"128","author":"A Pishgahi","year":"2020","unstructured":"Pishgahi A, Abolhasan R, Danaii S, Amanifar B, Soltani-Zangbar MS, Zamani M, Kamrani A, Ghorbani F, Mehdizadeh A, Kafil HS, Jadidi-Niaragh F, Yousefi B, Hajialiloo M, Yousefi M. Immunological and oxidative stress biomarkers in ankylosing spondylitis patients with or without metabolic syndrome. Cytokine. 2020;128:155002.","journal-title":"Cytokine"},{"key":"1720_CR18","doi-asserted-by":"publisher","first-page":"1365761","DOI":"10.3389\/fphys.2024.1365761","volume":"15","author":"T Chomiuk","year":"2024","unstructured":"Chomiuk T, Niezgoda N, Mamcarz A, \u015ali\u017c D. Physical activity in metabolic syndrome. Front Physiol. 2024;15:1365761.","journal-title":"Front Physiol"},{"issue":"5","key":"1720_CR19","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1007\/s10067-006-0380-5","volume":"26","author":"D Malesci","year":"2007","unstructured":"Malesci D, Niglio A, Mennillo GA, Buono R, Valentini G, La Montagna G. High prevalence of metabolic syndrome in patients with ankylosing spondylitis. Clin Rheumatol. 2007;26(5):710\u20134.","journal-title":"Clin Rheumatol"},{"issue":"4","key":"1720_CR20","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s11739-020-02520-y","volume":"16","author":"G Cioffi","year":"2021","unstructured":"Cioffi G, Viapiana O, Tarantini L, Orsolini G, Idolazzi L, Sonographer FO, Dalbeni A, Gatti D, Fassio A, Rossini M, Giollo A. Clinical profile and outcome of patients with chronic inflammatory arthritis and metabolic syndrome. Intern Emerg Med. 2021;16(4):863\u201374.","journal-title":"Intern Emerg Med"},{"key":"1720_CR21","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.phrs.2018.01.009","volume":"133","author":"G Medina","year":"2018","unstructured":"Medina G, Vera-Lastra O, Peralta-Amaro AL, Jim\u00e9nez-Arellano MP, Saavedra MA, Cruz-Dom\u00ednguez MP, Jara LJ. Metabolic syndrome, autoimmunity and rheumatic diseases. Pharmacol Res. 2018;133:277\u201388.","journal-title":"Pharmacol Res"},{"issue":"1","key":"1720_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2046-4053-4-1","volume":"4","author":"D Moher","year":"2015","unstructured":"Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1.","journal-title":"Syst Rev"},{"key":"1720_CR23","unstructured":"Institute TJB, Checklist for Cohort Studies. 2017. https:\/\/jbi.global\/sites\/default\/files\/2019-05\/JBI_Critical_Appraisal-Checklist_for_Cohort_Studies2017_0.pdf"},{"key":"1720_CR24","unstructured":"Institute TJB, Ckecklist for Case Control Studies. 2017. https:\/\/jbi.global\/sites\/default\/files\/2019-05\/JBI_Critical_Appraisal-Checklist_for_Case_Control_Studies2017_0.pdf"},{"key":"1720_CR25","unstructured":"Institute JB. Checklist for Analytical Cross Sectional Studies, 2017. https:\/\/jbi.global\/sites\/default\/files\/2019-05\/JBI_Critical_Appraisal-Checklist_for_Analytical_Cross_Sectional_Studies2017_0.pdf"},{"issue":"2","key":"1720_CR26","doi-asserted-by":"publisher","first-page":"772","DOI":"10.17826\/cumj.841343","volume":"46","author":"MS Akaltun","year":"2021","unstructured":"Akaltun MS, Altindag \u00d6, Turan N, Aydeniz A, G\u00fcrsoy S, G\u00fcr A. Relationship between metabolic syndrome and vitamin D level in patients with ankylosing spondylitis. CUKUROVA Med J. 2021;46(2):772\u20139.","journal-title":"CUKUROVA Med J"},{"issue":"5","key":"1720_CR27","first-page":"215","volume":"1","author":"I Batmaz","year":"2011","unstructured":"Batmaz I, Karakoc M, Sariyildiz MA, Yazici S, Tahtasiz M, Atilgan Z, Cevik R, Nas K. Metabolic syndrome in patients with ankylosing spondylitis. J Endocrinol METABOLISM. 2011;1(5):215\u20139.","journal-title":"J Endocrinol METABOLISM"},{"issue":"2","key":"1720_CR28","first-page":"198","volume":"18","author":"B Kesikburun","year":"2018","unstructured":"Kesikburun B, Ek\u015fio\u011flu E, \u00c7akc\u0131 A. Metabolic syndrome in rheumatoid arthritis and ankylosing spondylitis. Ankara Med J. 2018;18(2):198\u2013206.","journal-title":"Ankara Med J"},{"issue":"1","key":"1720_CR29","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1756-185X.2009.01448.x","volume":"13","author":"I Sari","year":"2010","unstructured":"Sari I, Kebapcilar L, Taylan A, Bilgir O, Kozaci DL, Yildiz Y, Yuksel A, Gunay N, Akkoc N. Fetuin-A and interleukin-18 levels in ankylosing spondylitis. Int J Rheum Dis. 2010;13(1):75\u201381.","journal-title":"Int J Rheum Dis"},{"issue":"11","key":"1720_CR30","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.4066\/biomedicalresearch.62-18-412","volume":"29","author":"E Amaricai","year":"2018","unstructured":"Amaricai E, Catan L, Popa D, Dragoi M, Nemes D. Metabolic syndrome in patients with autoimmune inflammatory rheumatisms. Biomed Res. 2018;29(11):2416\u201320.","journal-title":"Biomed Res"},{"issue":"7","key":"1720_CR31","first-page":"813","volume":"20","author":"MS Chimenti","year":"2020","unstructured":"Chimenti MS, Fonti GL, Conigliaro P, Sunzini F, Scrivo R, Navarini L, Triggianese P, Peluso G, Scolieri P, Caccavale R, Diamanti AP, De Martino E, Salemi S, Birra D, Altobelli A, Paroli M, Bruzzese V, Lagana B, Gremese E, Conti F, Afeltra A, Perricone R. One-year effectiveness, retention rate, and safety of Secukinumab in ankylosing spondylitis and psoriatic arthritis: a real-life multicenter study, expert Opin. Biol Ther. 2020;20(7):813\u201321.","journal-title":"Biol Ther"},{"issue":"1","key":"1720_CR32","first-page":"5","volume":"6","author":"SE Hassani Sbai","year":"2019","unstructured":"Hassani Sbai SE, Rostom S, Amine B, Bahiri R. Prevalence of metabolic syndrome in patients with ankylosing spondylitis. J Orthop Rheumatol. 2019;6(1):5.","journal-title":"J Orthop Rheumatol"},{"key":"1720_CR33","doi-asserted-by":"crossref","unstructured":"Gado SE, Elwan SA, El Sharkawy AM, El-Banna HS, Evaluation of metabolic syndrome in egyptian patients with radiographic and non-radiographic axial spondyloarthritis (Cross Sectional Study). Rheumatology. 2022;30(2):28\u201334.","DOI":"10.35465\/30.2.2022.pp53-59"},{"key":"1720_CR34","doi-asserted-by":"crossref","unstructured":"Halvorsen S, Vollestad NK, Provan SA, Semb AG, Van der Heijde D, Hagen KB, Dagfinrud H. Cardiorespiratory fitness and cardiovascular risk in patients with ankylosing spondylitis: A Cross-Sectional comparative study. Arthritis Care Res. 2013;65(6):969\u201376.","DOI":"10.1002\/acr.21926"},{"key":"1720_CR35","doi-asserted-by":"crossref","unstructured":"Lai YF, Lin TY, Chien WC, Sun CA, Chung CH, Chen YH, Chen JT, Chen CL. Uveitis as a risk factor for developing acute myocardial infarction in ankylosing spondylitis: A National Population-Based longitudinal cohort study. Front Immunol 12 (2021).","DOI":"10.3389\/fimmu.2021.811664"},{"key":"1720_CR36","doi-asserted-by":"crossref","unstructured":"Lin TY, Lai YF, Chien WC, Chen YH, Sun CA, Chung CH, Chen JT, Chen CL. Association between endophthalmitis and the incidence of acute coronary syndrome in patients with ankylosing spondylitis: A nationwide, Population-Based cohort study. Front Immunol 13 (2022).","DOI":"10.3389\/fimmu.2022.843796"},{"key":"1720_CR37","doi-asserted-by":"crossref","unstructured":"Mok CC, Ko GT, Ho LY, Yu KL, Chan PT, To CH. Prevalence of atherosclerotic risk factors and the metabolic syndrome in patients with chronic inflammatory arthritis. Arthritis Care Res (Hoboken). 2011;63(2):195\u2013202.","DOI":"10.1002\/acr.20363"},{"key":"1720_CR38","unstructured":"Papadakis JA, Sidiropoulos PI, Karvounaris SA, Vrentzos GE, Spanakis EK, Ganotakis ES, Kritikos HD, Mikhailidis DP, Boumpas DT. High prevalence of metabolic syndrome and cardiovascular risk factors in men with ankylosing spondylitis on anti-TNFalpha treatment: correlation with disease activity. Clin Exp Rheumatol. 2009;27(2):292\u20138."},{"key":"1720_CR39","doi-asserted-by":"crossref","unstructured":"Petcharat C, Srinonprasert V, Chiowchanwisawakit P. Association between syndesmophyte and metabolic syndrome in patients with psoriatic arthritis or ankylosing spondylitis: a cross-sectional study. BMC Musculoskelet Disord 22(1) (2021).","DOI":"10.1186\/s12891-021-04222-8"},{"key":"1720_CR40","doi-asserted-by":"crossref","unstructured":"Genre F, L\u00f3pez-Mej\u00edas R, Miranda-Filloy JA, Ubilla B, Mijares V, Carnero-L\u00f3pez B, G\u00f3mez-Acebo I, Dierssen-Sotos T, Remuzgo-Mart\u00ednez S, Blanco R, Pina T, Gonz\u00e1lez-Juanatey C, Llorca J. Gonz\u00e1lez-Gay, Anti-TNF-\u03b1 therapy reduces endothelial cell activation in non-diabetic ankylosing spondylitis patients. Rheumatol Int. 2015;35(12):2069\u201378.","DOI":"10.1007\/s00296-015-3314-1"},{"key":"1720_CR41","doi-asserted-by":"crossref","unstructured":"Fahed G, Aoun L, Bou Zerdan M, Allam S, Bou Zerdan M, Bouferraa Y, Assi HI. Metabolic Syndrome: Updates on Pathophysiology and Management in 2021, International journal of molecular sciences 23(2) (2022).","DOI":"10.3390\/ijms23020786"},{"key":"1720_CR42","doi-asserted-by":"crossref","unstructured":"Estefes-Duarte JA, Espinosa-S\u00e1nchez A, P\u00e9rez-Hern\u00e1ndez N, Ortiz MI. E. Fern\u00e1ndez-Mart\u00ednez, Mechanisms of Bioactive Lipids to Modulate Master Regulators of Lipid Homeostasis and Inflammation in Metabolic Syndrome, Current pharmaceutical biotechnology (2024).","DOI":"10.2174\/0113892010340506241014112341"},{"key":"1720_CR43","doi-asserted-by":"crossref","unstructured":"Jeong J, Yu J. Prevalence and influencing factors of metabolic syndrome among persons with physical disabilities. Asian Nurs Res. 2018;12(1):50\u20135.","DOI":"10.1016\/j.anr.2018.02.001"},{"issue":"3","key":"1720_CR44","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s00296-019-04494-3","volume":"40","author":"EH Coulter","year":"2020","unstructured":"Coulter EH, McDonald MT, Cameron S, Siebert S, Paul L. Physical activity and sedentary behaviour and their associations with clinical measures in axial spondyloarthritis. Rheumatol Int. 2020;40(3):375\u201381.","journal-title":"Rheumatol Int"},{"issue":"3","key":"1720_CR45","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/ar2397","volume":"10","author":"PI Sidiropoulos","year":"2008","unstructured":"Sidiropoulos PI, Karvounaris SA, Boumpas DT. Metabolic syndrome in rheumatic diseases: epidemiology, pathophysiology, and clinical implications. Arthritis Res Therapy. 2008;10(3):207.","journal-title":"Arthritis Res Therapy"},{"issue":"1","key":"1720_CR46","doi-asserted-by":"publisher","first-page":"e70329","DOI":"10.1111\/jcmm.70329","volume":"29","author":"Y Shi","year":"2025","unstructured":"Shi Y, Guan S, Liu X, Zhai H, Zhang Y, Liu J, Yang W, Wang Z. Genetic commonalities between metabolic syndrome and rheumatic diseases through disease interactome modules. J Cell Mol Med. 2025;29(1):e70329.","journal-title":"J Cell Mol Med"},{"issue":"7","key":"1720_CR47","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.3899\/jrheum.140021","volume":"41","author":"M Haroon","year":"2014","unstructured":"Haroon M, Gallagher P, Heffernan E, FitzGerald O. High prevalence of metabolic syndrome and of insulin resistance in psoriatic arthritis is associated with the severity of underlying disease. J Rheumatol. 2014;41(7):1357\u201365.","journal-title":"J Rheumatol"},{"key":"1720_CR48","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.bcp.2019.03.030","volume":"165","author":"V Francisco","year":"2019","unstructured":"Francisco V, Ruiz-Fern\u00e1ndez C, Pino J, Mera A, Gonz\u00e1lez-Gay MA, G\u00f3mez R, Lago F, Mobasheri A, Gualillo O. Adipokines: linking metabolic syndrome, the immune system, and arthritic diseases. Biochem Pharmacol. 2019;165:196\u2013206.","journal-title":"Biochem Pharmacol"},{"key":"1720_CR49","doi-asserted-by":"crossref","unstructured":"Clemente-Su\u00e1rez VJ, Redondo-Fl\u00f3rez L, Beltr\u00e1n-Velasco AI, Mart\u00edn-Rodr\u00edguez A, Mart\u00ednez-Guardado I, Navarro-Jim\u00e9nez E, Laborde-C\u00e1rdenas CC. J.F. Tornero-Aguilera, The Role of Adipokines in Health and Disease, Biomedicines 11(5) (2023).","DOI":"10.3390\/biomedicines11051290"},{"key":"1720_CR50","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.cca.2012.12.007","volume":"417","author":"A Yadav","year":"2013","unstructured":"Yadav A, Kataria MA, Saini V, Yadav A. Role of leptin and adiponectin in insulin resistance. Clin Chim Acta. 2013;417:80\u20134.","journal-title":"Clin Chim Acta"},{"issue":"9","key":"1720_CR51","doi-asserted-by":"publisher","first-page":"e0239818","DOI":"10.1371\/journal.pone.0239818","volume":"15","author":"HJ Dong","year":"2020","unstructured":"Dong HJ, Larsson B, Rivano Fischer M, Gerdle B. Facing obesity in pain rehabilitation clinics: profiles of physical activity in patients with chronic pain and obesity-A study from the Swedish quality registry for pain rehabilitation (SQRP). PLoS ONE. 2020;15(9):e0239818.","journal-title":"PLoS ONE"},{"issue":"4","key":"1720_CR52","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/lipd.12302","volume":"56","author":"MR Azarpazhooh","year":"2021","unstructured":"Azarpazhooh MR, Najafi F, Darbandi M, Kiarasi S, Oduyemi T, Spence JD. Triglyceride\/High-Density lipoprotein cholesterol ratio: A clue to metabolic syndrome, insulin resistance, and severe atherosclerosis. Lipids. 2021;56(4):405\u201312.","journal-title":"Lipids"},{"issue":"1","key":"1720_CR53","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1097\/MCO.0000000000000243","volume":"19","author":"LJ Dominguez","year":"2016","unstructured":"Dominguez LJ, Barbagallo M. The biology of the metabolic syndrome and aging. Curr Opin Clin Nutr Metab Care. 2016;19(1):5\u201311.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"7","key":"1720_CR54","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1001\/archinte.165.7.777","volume":"165","author":"BH Goodpaster","year":"2005","unstructured":"Goodpaster BH, Krishnaswami S, Harris TB, Katsiaras A, Kritchevsky SB, Simonsick EM, Nevitt M, Holvoet P, Newman AB. Obesity, regional body fat distribution, and the metabolic syndrome in older men and women. Arch Intern Med. 2005;165(7):777\u201383.","journal-title":"Arch Intern Med"},{"issue":"3","key":"1720_CR55","doi-asserted-by":"publisher","first-page":"93","DOI":"10.18773\/austprescr.2015.034","volume":"38","author":"M Harrison","year":"2015","unstructured":"Harrison M. Erythrocyte sedimentation rate and C-reactive protein. Australian Prescriber. 2015;38(3):93\u20134.","journal-title":"Australian Prescriber"},{"issue":"10","key":"1720_CR56","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3928\/00904481-20140924-10","volume":"43","author":"MK Litao","year":"2014","unstructured":"Litao MK, Kamat D. Erythrocyte sedimentation rate and C-reactive protein: how best to use them in clinical practice. Pediatr Ann. 2014;43(10):417\u201320.","journal-title":"Pediatr Ann"},{"issue":"11","key":"1720_CR57","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1002\/art.24838","volume":"61","author":"MK de Vries","year":"2009","unstructured":"de Vries MK, van Eijk IC, van der Horst-Bruinsma IE, Peters MJ, Nurmohamed MT, Dijkmans BA, Hazenberg BP, Wolbink GJ. Erythrocyte sedimentation rate, C-reactive protein level, and serum amyloid a protein for patient selection and monitoring of anti-tumor necrosis factor treatment in ankylosing spondylitis. Arthritis Rheum. 2009;61(11):1484\u201390.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"1720_CR58","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1097\/BOR.0b013e3283470f23","volume":"23","author":"P Machado","year":"2011","unstructured":"Machado P, van der Heijde D. How to measure disease activity in axial spondyloarthritis? Curr Opin Rheumatol. 2011;23(4):339\u201345.","journal-title":"Curr Opin Rheumatol"},{"key":"1720_CR59","doi-asserted-by":"crossref","unstructured":"Ferraz-Amaro I, Rueda-Gotor J, Genre F, Corrales A, Blanco R, Portilla V, Gonz\u00e1lez Maz\u00f3n I, Llorca J, Exp\u00f3sito R, Vicente EF, Quevedo-Abeledo JC, Rodr\u00edguez-Lozano C, Ortega-Castro R, Ladehesa-Pineda ML, Fern\u00e1ndez-Carballido C, Mart\u00ednez-Vidal MP, Castro-Corredor D, Anino-Fern\u00e1ndez J, Garc\u00eda ML, Vivar E, Gal\u00edndez-Agirregoikoa D, Peiteado C, Plasencia-Rodr\u00edguez E, Montes Perez C, Fern\u00e1ndez D\u00edaz S, Casta\u00f1eda M. Gonz\u00e1lez-Gay, potential relation of cardiovascular risk factors to disease activity in patients with axial spondyloarthritis, therapeutic advances in musculoskeletal disease 13 (2021) 1759720x211033755.","DOI":"10.1177\/1759720X211033755"},{"key":"1720_CR60","doi-asserted-by":"publisher","first-page":"856654","DOI":"10.3389\/fmed.2022.856654","volume":"9","author":"YH Chen","year":"2022","unstructured":"Chen YH, Huang WN, Chen YM, Lai KL, Hsieh TY, Hung WT, Lin CT, Tseng CW, Tang KT, Chou YY, Wu YD, Huang CY, Hsieh CW, Chen YJ, Liao YW, Chen HH. The BASDAI Cut-Off for disease activity corresponding to the ASDAS scores in a Taiwanese cohort of ankylosing spondylitis. Front Med. 2022;9:856654.","journal-title":"Front Med"},{"key":"1720_CR61","doi-asserted-by":"crossref","unstructured":"Van der Zee-Neuen A, Bogensberger K, Fuchs J, Wildburger S, Ritter M, AB0937 improvements in disease activity and functional impairment after multimodal SPA therapy in ankylosing spondylitis patients. Ann Rheum Dis. 2024;83:1778.","DOI":"10.1136\/annrheumdis-2024-eular.827"},{"key":"1720_CR62","doi-asserted-by":"crossref","unstructured":"Aytekin E, Ozgonenel L, Coskun H, Dede BT, Demir SE. Use of the Oswestry Disability Index in ankylosing spondylitis, Revista da Associacao Medica Brasileira (1992) 69(12) (2023) e20230927.","DOI":"10.1590\/1806-9282.20230927"},{"key":"1720_CR63","doi-asserted-by":"crossref","unstructured":"Stanciu S, Rusu E, Miricescu D, Radu AC, Axinia B, Vrabie AM, Ionescu R, Jinga M, Sirbu CA. Links between metabolic syndrome and hypertension: the relationship with the current antidiabetic drugs. Metabolites 13(1) (2023).","DOI":"10.3390\/metabo13010087"},{"issue":"4","key":"1720_CR64","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1089\/met.2006.4.287","volume":"4","author":"SS Franklin","year":"2006","unstructured":"Franklin SS. Hypertension in the metabolic syndrome. Metab Syndr Relat Disord. 2006;4(4):287\u201398.","journal-title":"Metab Syndr Relat Disord"},{"key":"1720_CR65","doi-asserted-by":"crossref","unstructured":"Jung JY, Oh CM, Choi JM, Ryoo JH, Chung PW, Hong HP, Park SK. Levels of systolic and diastolic blood pressure and their relation to incident metabolic syndrome. Cardiology. 2019;142(4):224\u201331.","DOI":"10.1159\/000499867"},{"issue":"1","key":"1720_CR66","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1186\/s12889-016-3789-z","volume":"16","author":"IO Ajayi","year":"2016","unstructured":"Ajayi IO, Adebamowo C, Adami HO, Dalal S, Diamond MB, Bajunirwe F, Guwatudde D, Njelekela M, Nankya-Mutyoba J, Chiwanga FS, Volmink J, Kalyesubula R, Laurence C, Reid TG, Dockery D, Hemenway D, Spiegelman D, Holmes MD. Urban-rural and geographic differences in overweight and obesity in four sub-Saharan African adult populations: a multi-country cross-sectional study. BMC Public Health. 2016;16(1):1126.","journal-title":"BMC Public Health"},{"key":"1720_CR67","doi-asserted-by":"crossref","unstructured":"Sartorius B, Veerman LJ, Manyema M, Chola L, Hofman K. Determinants of obesity and associated population attributability, South Africa: empirical evidence from a National panel survey, 2008\u20132012. PLoS ONE. 2015;10(6):e0130218.","DOI":"10.1371\/journal.pone.0130218"},{"issue":"10","key":"1720_CR68","doi-asserted-by":"publisher","first-page":"e017344","DOI":"10.1136\/bmjopen-2017-017344","volume":"7","author":"DA Amugsi","year":"2017","unstructured":"Amugsi DA, Dimbuene ZT, Mberu B, Muthuri S, Ezeh AC. Prevalence and time trends in overweight and obesity among urban women: an analysis of demographic and health surveys data from 24 African countries, 1991\u20132014. BMJ Open. 2017;7(10):e017344.","journal-title":"BMJ Open"},{"issue":"3","key":"1720_CR69","doi-asserted-by":"publisher","first-page":"986","DOI":"10.4269\/ajtmh.19-0644","volume":"103","author":"C Moucheraud","year":"2020","unstructured":"Moucheraud C, McBride K. Variability in health care quality measurement among studies using service provision assessment data from Low- and Middle-Income countries: A systematic review. Am J Trop Med Hyg. 2020;103(3):986\u201392.","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"1720_CR70","doi-asserted-by":"publisher","first-page":"e054397","DOI":"10.1136\/bmjopen-2021-054397","volume":"12","author":"ZT Tessema","year":"2022","unstructured":"Tessema ZT, Worku MG, Tesema GA, Alamneh TS, Teshale AB, Yeshaw Y, Alem AZ, Ayalew HG, Liyew AM. Determinants of accessing healthcare in Sub-Saharan Africa: a mixed-effect analysis of recent demographic and health surveys from 36 countries. BMJ Open. 2022;12(1):e054397.","journal-title":"BMJ Open"},{"key":"1720_CR71","doi-asserted-by":"publisher","first-page":"671682","DOI":"10.3389\/fgene.2021.671682","volume":"12","author":"X Wu","year":"2021","unstructured":"Wu X, Wang G, Zhang L, Xu H. Genetics of ankylosing Spondylitis-Focusing on the ethnic difference between East Asia and Europe. Front Genet. 2021;12:671682.","journal-title":"Front Genet"},{"key":"1720_CR72","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.gene.2018.05.092","volume":"670","author":"N Dashti","year":"2018","unstructured":"Dashti N, Mahmoudi M, Aslani S, Jamshidi A. HLA-B*27 subtypes and their implications in the pathogenesis of ankylosing spondylitis. Gene. 2018;670:15\u201321.","journal-title":"Gene"},{"issue":"4","key":"1720_CR73","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3109\/s10165-001-8056-0","volume":"11","author":"NK Mehra","year":"2001","unstructured":"Mehra NK, Kanga U. Molecular diversity of the HLA-B27 gene and its association with disease. Mod Rheumatol. 2001;11(4):275\u201385.","journal-title":"Mod Rheumatol"},{"key":"1720_CR74","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1741-7015-9-48","volume":"9","author":"E Kassi","year":"2011","unstructured":"Kassi E, Pervanidou P, Kaltsas G, Chrousos G. Metabolic syndrome: definitions and controversies. BMC Med. 2011;9:48.","journal-title":"BMC Med"},{"key":"1720_CR75","doi-asserted-by":"crossref","unstructured":"Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity, Circulation 120(16) (2009) 1640-5.","DOI":"10.1161\/CIRCULATIONAHA.109.192644"},{"issue":"11","key":"1720_CR76","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/acr2.11316","volume":"3","author":"JR Curtis","year":"2021","unstructured":"Curtis JR, Winthrop K, Bohn RL, Suruki R, Siegel S, Stark JL, Xie F, Yun H, Chen L, Deodhar A. The annual diagnostic prevalence of ankylosing spondylitis and axial spondyloarthritis in the united States using medicare and marketscan databases. ACR Open Rheumatol. 2021;3(11):743\u201352.","journal-title":"ACR Open Rheumatol"},{"issue":"25","key":"1720_CR77","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","volume":"106","author":"Third Report of the National Cholesterol Education Program (NCEP)","year":"2002","unstructured":"Third Report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel III) final report. Circulation. 2002;106(25):3143\u2013421.","journal-title":"Circulation"},{"issue":"5\u20136","key":"1720_CR78","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1242\/dmm.001180","volume":"2","author":"PL Huang","year":"2009","unstructured":"Huang PL. A comprehensive definition for metabolic syndrome. Dis Model Mech. 2009;2(5\u20136):231\u20137.","journal-title":"Dis Model Mech"},{"key":"1720_CR79","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1186\/1471-2458-9-484","volume":"9","author":"CC Lin","year":"2009","unstructured":"Lin CC, Liu CS, Li CI, Lin WY, Lai MM, Lin T, Chang PC, Lee YD, Chen CC, Lin CH, Yang CW, Hsiao CY, Chen W, Li TC. The relation of metabolic syndrome according to five definitions to cardiovascular risk factors\u2013a population-based study. BMC Public Health. 2009;9:484.","journal-title":"BMC Public Health"}],"container-title":["Diabetology & Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-025-01720-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-025-01720-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-025-01720-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T10:04:22Z","timestamp":1747389862000},"score":1,"resource":{"primary":{"URL":"https:\/\/dmsjournal.biomedcentral.com\/articles\/10.1186\/s13098-025-01720-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,16]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1720"],"URL":"https:\/\/doi.org\/10.1186\/s13098-025-01720-w","relation":{},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,16]]},"assertion":[{"value":"10 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"158"}}